RBC
BIIB icon

Ronald Blue & Co’s Biogen BIIB Stock Holding History

Ronald Blue & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,431
Closed -$578K – 313
2015
Q2 		$578K Sell
1,431
-314
-18% -$126K 0.03% 148
2015
Q1 		$737K Sell
1,745
-270
-13% -$106K 0.04% 121
2014
Q4 		$684K Sell
2,015
-293
-13% -$94.8K 0.03% 123
2014
Q3 		$763K Buy
2,308
+241
+12% +$79.5K 0.05% 107
2014
Q2 		$652K Buy
2,067
+6
+0.3% +$1.81K 0.04% 137
2014
Q1 		$630K Sell
2,061
-27
-1% -$8.57K 0.05% 124
2013
Q4 		$584K Buy
2,088
+9
+0.4% +$2.33K 0.04% 126
2013
Q3 		$501K Buy
2,079
+1,879
+940% +$421K 0.04% 127
2013
Q2 		$43K Buy
+200
New +$42.7K ﹤0.01% 192

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Ronald Blue & Co's BIIB Position: Q3 2015 in Review

Ronald Blue & Co sold out of Biogen (BIIB) in Q3 2015, closing a stake of 1,431 shares — an estimated $578K sold.

Ronald Blue & Co first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $763K in Q3 2014. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Ronald Blue & Co reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Ronald Blue & Co sold 1,431 Biogen shares in Q3 2015, an estimated $578K.
  • Ronald Blue & Co first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
  • Ronald Blue & Co's Biogen position peaked at $763K in Q3 2014.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Ronald Blue & Co's 13F filing for Q3 2015, filed 13 Nov 2015.